These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3556299)

  • 1. [Evaluation of an immunological test for detecting occult fecal blood for case-finding in colorectal tumors].
    Briançon S; Houot O; de Souza M; Collin JF; Siest G; Deschamps JP
    Gastroenterol Clin Biol; 1987 Mar; 11(3):194-200. PubMed ID: 3556299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of occult blood in stools: comparison of three gaiac tests and a latex agglutination test.
    Favennec L; Kapel N; Meillet D; Chochillon C; Gobert JG
    Ann Biol Clin (Paris); 1992; 50(5):311-3. PubMed ID: 1485687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of occult blood tests over a six-day period.
    Farrands PA; Hardcastle JD
    Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient compliance with screening for fecal occult blood in family practice.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    CMAJ; 1987 Aug; 137(3):195-8. PubMed ID: 3607662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of the haemoccult test in colorectal tumours (author's transl)].
    Schewe S; Feifel G; Heldwein W; Weinzierl M; Wolf W; Bolte HD; Konrad E
    Dtsch Med Wochenschr; 1979 Feb; 104(7):253-6. PubMed ID: 761519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early detection of colorectal cancers by detection of occult blood in feces using Krypto-Haem SSW].
    Uhlig K; Lampe J; Jacobasch KH
    Z Gesamte Inn Med; 1986 Dec; 41(23):660-3. PubMed ID: 3577258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms.
    Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K
    Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for colorectal cancer with the Haemoccult test (author's transl)].
    Gnauck R
    Leber Magen Darm; 1977 Feb; 7(1):32-5. PubMed ID: 839951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
    Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.